PlexusDx specializes in precision GLP-1 therapy, offering multiple medication pathways and genetic testing to match your individual biology
Visit www.fda.gov/medwatch or call 1-800-FDA-1088
The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Ozempic in the UK based on extensive clinical trial data demonstrating its efficacy and safety profile
The FDA prescribing information for semaglutide products does not list laxatives among medications that should be avoided, nor does it warn against their concurrent use
Contact your healthcare provider immediately if you experience painful urination, blood in urine, fever, inability to urinate despite urgency, severe abdominal pain, signs of dehydration, or blood glucose above 300 mg/dL with ketones present
Limiting these may reduce discomfort